Fortis Healthcare Limited Latest Updates

$FORTIS FY26 Full-Year & Q4 Financial Surge For the full financial year 2025-26, Fortis Healthcare recorded a strong financial performance with consolidated revenue growing 17.3% year-on-year to ₹9,128 crore. Full-year net profit (PAT) jumped 31.5% to ₹1,064 crore, driven by operational efficiencies that expanded consolidated EBITDA margins to 22.8%. In the final quarter ended March 31, 2026, consolidated net profit surged 44.2% YoY to ₹271 crore. Bed Capacity & Network Expansion The company executed a major network footprint scaling strategy, adding approximately 500 new beds to its system in fiscal year 2026. This inorganic growth was driven by the key acquisitions of People Tree Hospital in Bengaluru and Shrimann Hospital in Jalandhar, combined with a new long-term lease operation agreement for a hospital asset in Greater Noida. Management is targeting short-term margin goals of 25% through an aggressive 2,000-bed pipeline expansion. Specialty & Diagnostics Mix The hospital business drove 85% of total group revenues, supported by a 15% annual increase in occupied beds and a 66% surge in robotic surgery volumes. The core top-six medical specialties (led by Renal Sciences and Orthopedics) accounted for 62% of overall hospital revenue. Meanwhile, the diagnostics arm (Agilus Diagnostics) added 125 new customer touchpoints, bringing its network total to 4,445 while processing 40.8 million individual tests over the year. Strategic Healthcare Startup Accelerator In its latest strategic development, Fortis Healthcare and its parent entity IHH Healthcare concluded the demo day for the inaugural IHH Catalyst | Fortis India Edition startup accelerator program. Following a 12-week clinical validation framework, the 24x7 Tele ICU platform eNext ICU was named the winner, alongside RNT Health Insights (AI-powered endoscopic cancer devices) and Cartogene Therapeutics (CAR T-cell therapies) securing the top runner-up spots for future medical ecosystem deployment.